Plasmacytoid dendritic cells control homeostasis of megakaryopoiesis.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
10 Jul 2024
Historique:
received: 13 08 2021
accepted: 04 06 2024
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 10 7 2024
Statut: aheadofprint

Résumé

Platelet homeostasis is essential for vascular integrity and immune defence

Identifiants

pubmed: 38987596
doi: 10.1038/s41586-024-07671-y
pii: 10.1038/s41586-024-07671-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

van der Meijden, P. E. J. & Heemskerk, J. W. M. Platelet biology and functions: new concepts and clinical perspectives. Nat. Rev. Cardiol. 16, 166–179 (2019).
pubmed: 30429532 doi: 10.1038/s41569-018-0110-0
Gaertner, F. & Massberg, S. Patrolling the vascular borders: platelets in immunity to infection and cancer. Nat. Rev. Immunol. 19, 747–760 (2019).
pubmed: 31409920 doi: 10.1038/s41577-019-0202-z
Machlus, K. R. & Italiano, J. E. Jr. The incredible journey: from megakaryocyte development to platelet formation. J. Cell Biol. 201, 785–796 (2013).
pubmed: 23751492 pmcid: 3678154 doi: 10.1083/jcb.201304054
Noetzli, L. J., French, S. L. & Machlus, K. R. New insights into the differentiation of megakaryocytes from hematopoietic progenitors. Arterioscler. Thromb. Vasc. Biol. 39, 1288–1300 (2019).
pubmed: 31043076 pmcid: 6594866 doi: 10.1161/ATVBAHA.119.312129
Reizis, B. Plasmacytoid dendritic cells: development, regulation, and function. Immunity 50, 37–50 (2019).
pubmed: 30650380 pmcid: 6342491 doi: 10.1016/j.immuni.2018.12.027
McArthur, K., Chappaz, S. & Kile, B. T. Apoptosis in megakaryocytes and platelets: the life and death of a lineage. Blood 131, 605–610 (2018).
pubmed: 29259001 doi: 10.1182/blood-2017-11-742684
Junt, T. et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 317, 1767 (2007).
pubmed: 17885137 doi: 10.1126/science.1146304
Meizlish, M. L., Franklin, R. A., Zhou, X., & Medzhitov, R. Tissue homeostasis and inflammation. Annu. Rev. Immunol. 39, 557–581 (2021).
pubmed: 33651964 doi: 10.1146/annurev-immunol-061020-053734
Kunisaki, Y. et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502, 637–643 (2013).
pubmed: 24107994 pmcid: 3821873 doi: 10.1038/nature12612
Sanjuan-Pla, A. et al. Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature 502, 232–236 (2013).
pubmed: 23934107 doi: 10.1038/nature12495
Stegner, D. et al. Thrombopoiesis is spatially regulated by the bone marrow vasculature. Nat. Commun. 8, 127 (2017).
pubmed: 28743899 pmcid: 5527048 doi: 10.1038/s41467-017-00201-7
Eto, K. & Kunishima, S. Linkage between the mechanisms of thrombocytopenia and thrombopoiesis. Blood 127, 1234–1241 (2016).
pubmed: 26787737 pmcid: 4786834 doi: 10.1182/blood-2015-07-607903
Bunting, S. et al. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood 90, 3423–3429 (1997).
pubmed: 9345025 doi: 10.1182/blood.V90.9.3423
Levin, J. et al. Thrombocytopenic c-mpl
pubmed: 11493447 doi: 10.1182/blood.V98.4.1019
Luis, T. C. et al. Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner. Nat. Commun. 14, 6062 (2023).
pubmed: 37770432 pmcid: 10539537 doi: 10.1038/s41467-023-41691-y
Pinho, S. et al. Lineage-biased hematopoietic stem cells are regulated by distinct niches. Dev. Cell 44, 634–641 (2018).
pubmed: 29456137 pmcid: 5886750 doi: 10.1016/j.devcel.2018.01.016
Kaur, S. et al. Role of bone marrow macrophages in controlling homeostasis and repair in bone and bone marrow niches. Semin. Cell Dev. Biol. 61, 12–21 (2017).
pubmed: 27521519 doi: 10.1016/j.semcdb.2016.08.009
Frisch, B. J. et al. Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B. JCI Insight https://doi.org/10.1172/jci.insight.124213 (2019).
Weinberger, T. et al. Ontogeny of arterial macrophages defines their functions in homeostasis and inflammation. Nat. Commun. 11, 4549 (2020).
pubmed: 32917889 pmcid: 7486394 doi: 10.1038/s41467-020-18287-x
Stoneman, V. et al. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 100, 884–893 (2007).
pubmed: 17322176 pmcid: 2040259 doi: 10.1161/01.RES.0000260802.75766.00
Gilliet, M., Cao, W. & Liu, Y. J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594–606 (2008).
pubmed: 18641647 doi: 10.1038/nri2358
Iparraguirre, A. et al. Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide. J. Leukoc. Biol. 83, 610–620 (2008).
pubmed: 18029397 doi: 10.1189/jlb.0807511
Swiecki, M. & Colonna, M. The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol. 15, 471–485 (2015).
pubmed: 26160613 pmcid: 4808588 doi: 10.1038/nri3865
Swiecki, M., Gilfillan, S., Vermi, W., Wang, Y. & Colonna, M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8
pubmed: 21130004 pmcid: 3588567 doi: 10.1016/j.immuni.2010.11.020
Blasius, A. L. et al. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177, 3260–3265 (2006).
pubmed: 16920966 doi: 10.4049/jimmunol.177.5.3260
Cisse, B. et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135, 37–48 (2008).
pubmed: 18854153 pmcid: 2631034 doi: 10.1016/j.cell.2008.09.016
Sadeh, R. et al. ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin. Nat. Biotechnol. 39, 586–598 (2021).
pubmed: 33432199 pmcid: 7610786 doi: 10.1038/s41587-020-00775-6
Rao, T. N. et al. JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality. Blood 137, 2139–2151 (2021).
pubmed: 33667305 pmcid: 8103999 doi: 10.1182/blood.2020005563
Haas, S. et al. Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors. Cell Stem Cell 17, 422–434 (2015).
pubmed: 26299573 doi: 10.1016/j.stem.2015.07.007
Paul, F. et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 163, 1663–1677 (2015).
pubmed: 26627738 doi: 10.1016/j.cell.2015.11.013
Evrard, M. et al. Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and effector functions. Immunity 48, 364–379 (2018).
pubmed: 29466759 doi: 10.1016/j.immuni.2018.02.002
Olsson, A. et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature 537, 698–702 (2016).
pubmed: 27580035 pmcid: 5161694 doi: 10.1038/nature19348
Psaila, B. et al. Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways. Genome Biol. 17, 83 (2016).
pubmed: 27142433 pmcid: 4855892 doi: 10.1186/s13059-016-0939-7
Ramasz, B. et al. Hematopoietic stem cell response to acute thrombocytopenia requires signaling through distinct receptor tyrosine kinases. Blood 134, 1046–1058 (2019).
pubmed: 31434705 doi: 10.1182/blood.2019000721
Dorrello, N. V. et al. S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314, 467–471 (2006).
pubmed: 17053147 doi: 10.1126/science.1130276
Kroczynska, B., Sharma, B., Eklund, E. A., Fish, E. N. & Platanias, L. C. Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses. Mol. Cell. Biol. 32, 2809–2822 (2012).
pubmed: 22586265 pmcid: 3416205 doi: 10.1128/MCB.00310-12
Swiecki, M. & Colonna, M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 234, 142–162 (2010).
pubmed: 20193017 pmcid: 3507434 doi: 10.1111/j.0105-2896.2009.00881.x
Iannacone, M. et al. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 465, 1079–1083 (2010).
pubmed: 20577213 pmcid: 2892812 doi: 10.1038/nature09118
Bernardes, J. P. et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity 53, 1296–1314 (2020).
pubmed: 33296687 pmcid: 7689306 doi: 10.1016/j.immuni.2020.11.017
Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036–1045 (2020).
pubmed: 32416070 pmcid: 7227586 doi: 10.1016/j.cell.2020.04.026
Mesev, E. V., LeDesma, R. A. & Ploss, A. Decoding type I and III interferon signalling during viral infection. Nat. Microbiol. 4, 914–924 (2019).
pubmed: 30936491 pmcid: 6554024 doi: 10.1038/s41564-019-0421-x
Stutte, S. et al. Type I interferon mediated induction of somatostatin leads to suppression of ghrelin and appetite thereby promoting viral immunity in mice. Brain Behav. Immun. 95, 429–443 (2021).
pubmed: 33895286 doi: 10.1016/j.bbi.2021.04.018
Gough, D. J., Messina, N. L., Clarke, C. J., Johnstone, R. W. & Levy, D. E. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36, 166–174 (2012).
pubmed: 22365663 pmcid: 3294371 doi: 10.1016/j.immuni.2012.01.011
Essers, M. A. et al. IFNα activates dormant haematopoietic stem cells in vivo. Nature 458, 904–908 (2009).
pubmed: 19212321 doi: 10.1038/nature07815
Sato, T. et al. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat. Med. 15, 696–700 (2009).
pubmed: 19483695 doi: 10.1038/nm.1973
Iannacone, M. et al. Platelets prevent IFN-α/β-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc. Natl Acad. Sci. USA 105, 629–634 (2008).
pubmed: 18184798 pmcid: 2206587 doi: 10.1073/pnas.0711200105
Woo, A. J. et al. Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation. J. Clin. Invest. https://doi.org/10.1172/JCI40609 (2013).
Martin, T. G. & Shuman, M. A. Interferon-induced thrombocytopenia: Is it time for thrombopoietin? Hepatology 28, 1430–1432 (1998).
pubmed: 9794932 doi: 10.1002/hep.510280536
Yamane, A. et al. Interferon-α2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes. Blood 112, 542–550 (2008).
pubmed: 18523149 doi: 10.1182/blood-2007-12-125906
Lee-Sundlov, M. M. et al. Immune cells surveil aberrantly sialylated O-glycans on megakaryocytes to regulate platelet count. Blood 138, 2408–2424 (2021).
pubmed: 34324649 pmcid: 8662070 doi: 10.1182/blood.2020008238
Pinho, S. & Frenette, P. S. Haematopoietic stem cell activity and interactions with the niche. Nat. Rev. Mol. Cell Biol. 20, 303–320 (2019).
pubmed: 30745579 pmcid: 6483843 doi: 10.1038/s41580-019-0103-9
Bruns, I. et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat. Med. 20, 1315–1320 (2014).
pubmed: 25326802 pmcid: 4258871 doi: 10.1038/nm.3707
Zhao, M. et al. Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat. Med. 20, 1321–1326 (2014).
pubmed: 25326798 doi: 10.1038/nm.3706
Heazlewood, S. Y. et al. High ploidy large cytoplasmic megakaryocytes are hematopoietic stem cells regulators and essential for platelet production. Nat. Commun. 14, 2099 (2023).
pubmed: 37055407 pmcid: 10102126 doi: 10.1038/s41467-023-37780-7
Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369, 1210–1220 (2020).
pubmed: 32788292 pmcid: 7665312 doi: 10.1126/science.abc6261
Tiedt, R., Schomber, T., Hao-Shen, H. & Skoda, R. C. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 109, 1503–1506 (2007).
pubmed: 17032923 doi: 10.1182/blood-2006-04-020362
Buch, T. et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419–426 (2005).
pubmed: 15908920 doi: 10.1038/nmeth762
Muller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918–1921 (1994).
pubmed: 8009221 doi: 10.1126/science.8009221
Prigge, J. R. et al. Type I IFNs act upon hematopoietic progenitors to protect and maintain hematopoiesis during pneumocystis lung infection in mice. J Immunol 195, 5347–5357 (2015).
pubmed: 26519535 doi: 10.4049/jimmunol.1501553
Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661–665 (2007).
pubmed: 17251932 doi: 10.1038/nature05541
Hou, B., Reizis, B. & DeFranco, A. L. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 29, 272–282 (2008).
pubmed: 18656388 pmcid: 2847796 doi: 10.1016/j.immuni.2008.05.016
Duffield, J. S. et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56–65 (2005).
pubmed: 15630444 pmcid: 539199 doi: 10.1172/JCI200522675
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Förster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265–277 (1999).
pubmed: 10621974 doi: 10.1023/A:1008942828960
Opferman, J. T. et al. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426, 671–676 (2003).
pubmed: 14668867 doi: 10.1038/nature02067
Yuan, L. et al. A role of stochastic phenotype switching in generating mosaic endothelial cell heterogeneity. Nat. Commun. 7, 10160 (2016).
pubmed: 26744078 pmcid: 5154372 doi: 10.1038/ncomms10160
Birling, M. C. et al. A resource of targeted mutant mouse lines for 5,061 genes. Nat. Genet. 53, 416–419 (2021).
pubmed: 33833456 pmcid: 8397259 doi: 10.1038/s41588-021-00825-y
Fumagalli, V. et al. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion. Sci. Immunol. 7, eabl9929 (2022).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Krull, A., Buchholz, T. & Jug, F. Noise2Void - learning denoising from single noisy images. In 2019 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) (2019) 2124–2132 (IEEE, 2019).
Robinson, M. S. et al. Flow cytometric analysis of reticulated platelets: evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes. Br. J. Haematol. 100, 351–357 (1998).
pubmed: 9488626 doi: 10.1046/j.1365-2141.1998.00563.x
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 44, W3–W10 (2016).
pubmed: 27137889 pmcid: 4987906 doi: 10.1093/nar/gkw343
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
pubmed: 16199517 pmcid: 1239896 doi: 10.1073/pnas.0506580102
Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
pubmed: 12808457 doi: 10.1038/ng1180
Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
pubmed: 19131956 doi: 10.1038/nprot.2008.211
Metsalu, T. & Vilo, J. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 43, W566–W570 (2015).
pubmed: 25969447 pmcid: 4489295 doi: 10.1093/nar/gkv468
Pekayvaz, K. et al. Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation. Immunity 56, 2325–2341 (2023).
pubmed: 37652021 pmcid: 10588993 doi: 10.1016/j.immuni.2023.08.002
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
Young, M. D. & Behjati, S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. Gigascience https://doi.org/10.1093/gigascience/giaa151 (2020).
Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496–502 (2019).
pubmed: 30787437 pmcid: 6434952 doi: 10.1038/s41586-019-0969-x
Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
pubmed: 24658644 pmcid: 4122333 doi: 10.1038/nbt.2859
Aatonen, M. T. et al. Isolation and characterization of platelet-derived extracellular vesicles. J. Extracell. Vesicles https://doi.org/10.3402/jev.v3.24692 (2014).
Mead, T. J. & Lefebvre, V. in Skeletal Development and Repair: Methods and Protocols (ed. Hilton, M. J.) 233–243 (Humana Press, 2014).
Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).
pubmed: 27124452 pmcid: 4944528 doi: 10.1126/science.aad0501

Auteurs

Florian Gaertner (F)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany. f.gaertner@med.uni-muenchen.de.
Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria. f.gaertner@med.uni-muenchen.de.
DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany. f.gaertner@med.uni-muenchen.de.

Hellen Ishikawa-Ankerhold (H)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Susanne Stutte (S)

Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, LMU Munich, Planegg-Martinsried, Germany.
Walter Brendel Center of Experimental Medicine, University Hospital, LMU Munich, Munich, Germany.
Institute for Immunology, Faculty of Medicine, LMU Munich, Munich, Germany.

Wenwen Fu (W)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Jutta Weitz (J)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Anne Dueck (A)

DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.
Institute of Pharmacology and Toxicology, Technical University of Munich (TUM), Munich, Germany.

Bhavishya Nelakuditi (B)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
Institute of Computational Biology, Deutsches Forschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München, Neuherberg, Germany.
Department of Computer Science, TUM School of Computation, Information and Technology, Technical University of Munich, Garching, Germany.

Valeria Fumagalli (V)

Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Department of Dynamics of Immune Responses, Vita-Salute San Raffaele University, Milan, Italy.

Dominic van den Heuvel (D)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Larissa Belz (L)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Gulnoza Sobirova (G)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Zhe Zhang (Z)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Anna Titova (A)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Alejandro Martinez Navarro (AM)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Kami Pekayvaz (K)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.

Michael Lorenz (M)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Louisa von Baumgarten (L)

Department of Neurology, Ludwig-Maximilians-University School of Medicine, Munich, Germany.

Jan Kranich (J)

Institute for Immunology, Faculty of Medicine, LMU Munich, Munich, Germany.

Tobias Straub (T)

Biomedical Center, Bioinformatic Core facility, LMU Munich, Planegg-Martinsried, Germany.

Bastian Popper (B)

Biomedical Center, Core Facility Animal Models, LMU Munich, Planegg-Martinsried, Germany.

Vanessa Zheden (V)

Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria.

Walter Anton Kaufmann (WA)

Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria.

Chenglong Guo (C)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Guido Piontek (G)

Institute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany.

Saskia von Stillfried (S)

Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.

Peter Boor (P)

Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.

Marco Colonna (M)

Washington University, School of Medicine, St Louis, MO, USA.

Sebastian Clauß (S)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.

Christian Schulz (C)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.

Thomas Brocker (T)

Institute for Immunology, Faculty of Medicine, LMU Munich, Munich, Germany.

Barbara Walzog (B)

Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, LMU Munich, Planegg-Martinsried, Germany.
Walter Brendel Center of Experimental Medicine, University Hospital, LMU Munich, Munich, Germany.

Christoph Scheiermann (C)

Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, LMU Munich, Planegg-Martinsried, Germany.
Walter Brendel Center of Experimental Medicine, University Hospital, LMU Munich, Munich, Germany.
Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

William C Aird (WC)

Department of Medicine, Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Claus Nerlov (C)

MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Konstantin Stark (K)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.

Tobias Petzold (T)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.
Department of Cardiology, Angiology and Intensive Care Medicine, Campus Benjamin Franklin, Deutsches Herzzentrum der Charité (DHZC) University Hospital Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner site Berlin, Berlin, Germany.
Friede Springer - Centre of Cardiovascular Prevention @ Charité, Charité - University Medicine Berlin, Berlin, Germany.

Stefan Engelhardt (S)

DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.
Institute of Pharmacology and Toxicology, Technical University of Munich (TUM), Munich, Germany.

Michael Sixt (M)

Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria.

Robert Hauschild (R)

Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria.

Martina Rudelius (M)

Institute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany.

Robert A J Oostendorp (RAJ)

Laboratory of Stem Cell Physiology, Department of Internal Medicine III-Hematology and Oncology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Matteo Iannacone (M)

Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Department of Dynamics of Immune Responses, Vita-Salute San Raffaele University, Milan, Italy.

Matthias Heinig (M)

DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.
Institute of Computational Biology, Deutsches Forschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München, Neuherberg, Germany.
Department of Computer Science, TUM School of Computation, Information and Technology, Technical University of Munich, Garching, Germany.

Steffen Massberg (S)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany.

Classifications MeSH